You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 10,093,728

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,093,728

Title:	Pharmaceutical formulations of TNF-alpha antibodies
Abstract:	The present invention provides certain improved formulations of proteins. Specifically, the present invention provides use of certain excipients that are useful for stabilization of antibody preparations. Additionally, the novel formulations of the present invention prevents the formation of aggregates or fragments or modifications of protein in solution.
Inventor(s):	Mendiratta; Sanjeev Kumar (Ahmedabad, IN), Bandyopadhyay; Sanjay (Ahmedabad, IN), Patel; Chintan G. (Ahmedabad, IN)
Assignee:	CADILA HEALTHCARE LIMITED (Ahmedabad, IN)
Application Number:	14/383,533
Patent Claims:	1. A liquid pharmaceutical composition comprising: (a) an effective amount of adalimumab or an antigen binding portion thereof; (b) a stabilizer consisting essentially of: (i) from about 0.5% to about 10% arginine, or (ii) from about 0.5% to about 10% arginine and from about 1% to about 10% sorbitol; (c) 0.01% to 1% of a surfactant selected from polysorbate 80, polysorbate 20 or a combination thereof; and (d) 5-50 mM succinate buffer, pH 5.0 to 5.5. 2. The composition of claim 1, wherein the stabilizer consists essentially of 0.5% to about 10% arginine. 3. The composition of claim 1, wherein the stabilizer consists essentially of 5 mg/mL arginine. 4. The composition of claim 1, wherein the stabilizer consists essentially of 0.5% to about 10% arginine and from about 1% to about 10% sorbitol. 5. The composition of claim 1, wherein the stabilizer consists essentially of 5 mg/mL arginine and 10 mg/mL sorbitol. 6. The composition of claim 1, wherein the surfactant is polysorbate 80. 7. The composition of claim 6, wherein the surfactant comprises 0.1 mg/mL polysorbate 80. 8. The composition of claim 1, wherein the composition comprises 10 mM succinate buffer. 9. The composition of claim 1, further comprising a tonicity agent. 10. The composition of claim 9, wherein the tonicity agent comprises sodium chloride. 11. The composition of claim 10, wherein tonicity agent comprises from about 10 mM to about 150 mM sodium chloride.

Details for Patent 10,093,728

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	12/31/2002	⤷ Try a Trial	2032-03-07
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	02/21/2008	⤷ Try a Trial	2032-03-07
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	04/24/2013	⤷ Try a Trial	2032-03-07
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	09/23/2014	⤷ Try a Trial	2032-03-07
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	11/23/2015	⤷ Try a Trial	2032-03-07
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.